Skip to main content
NVDA+0.96%AAPL+0.04%GOOGL+0.86%MSFT+0.87%AMZN+0.71%TSM+2.75%SPCX+7.63%META+0.36%AVGO+2.08%TSLA+1.16%SKHY-0.06%MU+0.06%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.74%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.22%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.88%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.76%USDPLN-0.72%USDZAR-0.71%AUDCHF+0.63%USDMXN-0.58%USDSEK-0.53%AUDJPY+0.50%CHFSEK-0.47%GBPCHF+0.43%GBPTRY+0.41%EURHKD+0.41%USDDKK-0.39%AUDUSD+0.36%EURCNH+0.34%AUDCAD+0.34%AUDNZD+0.34%GBPZAR-0.33%EURPLN-0.33%GBPHKD+0.32%GBPJPY+0.31%EURZAR-0.31%NZDMXN-0.29%GBPMXN-0.28%EURCHF+0.28%NOKJPY+0.28%AUDDKK-0.26%EURAUD-0.25%GBPUSD+0.25%EURSGD+0.24%USDNOK-0.24%GBPCAD+0.24%GBPNZD+0.23%GBPSGD+0.22%NZDCHF+0.21%USDCHF+0.19%CADCHF+0.19%SGDJPY+0.18%CHFNOK-0.18%EURJPY+0.17%EURCZK-0.17%USDILS+0.16%EURNOK+0.16%GBPAUD-0.15%USDSGD-0.15%NZDSGD+0.14%EURSEK-0.14%EURGBP-0.13%AUDNOK-0.12%CHFJPY-0.11%EURUSD+0.11%NZDJPY+0.11%USDTRY+0.11%USDTHB+0.10%EURCAD+0.10%EURNZD+0.10%USDJPY+0.10%CHFSGD-0.09%CADJPY+0.09%USDCNH-0.05%USDCOP-0.04%AUDSGD-0.02%NZDCAD+0.01%NZDUSD+0.01%EURDKK+0.01%USDHKD+0.01%USDCAD0.00%UKOIL-2.43%USOIL-2.09%COCOA-1.36%W1+1.14%C1+0.83%COFFEE+0.82%GAUUSD+0.69%XAUUSD+0.69%COTTON+0.60%GAGUSD+0.57%XAGUSD+0.55%S1+0.52%BTCUSD+0.65%ETHUSD+6.15%USDTUSD-0.04%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.15%ZECUSDT+2.33%DOGEUSD-1.82%XMRUSDT-0.76%LINKUSD+3.21%XLMUSD+0.53%BCHUSDT+0.38%UNIUSD-2.22%LTCUSD-4.60%SUIUSD-0.96%HBARUSDT-0.25%TONUSD+12.52%TAOUSDT-0.59%AAVEUSD-1.26%DOTUSDT+0.28%ICPUSDT-4.15%ONDOUSDT+0.14%WLDUSDT+0.47%ARBUSDT-3.10%JUPUSDT-0.14%ATOMUSDT-0.58%INJUSDT+0.80%STXUSDT+0.08%FETUSDT-1.98%SEIUSDT-0.61%PYTHUSDT+1.02%TIAUSDT-1.42%IMXUSDT-1.75%GRTUSDT-0.64%OPUSDT-2.99%WIFUSDT+0.80%IOTAUSDT+4.29%AXSUSDT-0.24%POLUSDT+1.35%FARTCOINUSDT+2.13%EOSUSDT+3.34%DYDXUSDT-1.68%GALAUSDT-0.12%ORDIUSDT+1.11%NOTUSDT+1.29%RONINUSDT+2.94%NVDA+0.96%AAPL+0.04%GOOGL+0.86%MSFT+0.87%AMZN+0.71%TSM+2.75%SPCX+7.63%META+0.36%AVGO+2.08%TSLA+1.16%SKHY-0.06%MU+0.06%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.74%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.22%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.88%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.76%USDPLN-0.72%USDZAR-0.71%AUDCHF+0.63%USDMXN-0.58%USDSEK-0.53%AUDJPY+0.50%CHFSEK-0.47%GBPCHF+0.43%GBPTRY+0.41%EURHKD+0.41%USDDKK-0.39%AUDUSD+0.36%EURCNH+0.34%AUDCAD+0.34%AUDNZD+0.34%GBPZAR-0.33%EURPLN-0.33%GBPHKD+0.32%GBPJPY+0.31%EURZAR-0.31%NZDMXN-0.29%GBPMXN-0.28%EURCHF+0.28%NOKJPY+0.28%AUDDKK-0.26%EURAUD-0.25%GBPUSD+0.25%EURSGD+0.24%USDNOK-0.24%GBPCAD+0.24%GBPNZD+0.23%GBPSGD+0.22%NZDCHF+0.21%USDCHF+0.19%CADCHF+0.19%SGDJPY+0.18%CHFNOK-0.18%EURJPY+0.17%EURCZK-0.17%USDILS+0.16%EURNOK+0.16%GBPAUD-0.15%USDSGD-0.15%NZDSGD+0.14%EURSEK-0.14%EURGBP-0.13%AUDNOK-0.12%CHFJPY-0.11%EURUSD+0.11%NZDJPY+0.11%USDTRY+0.11%USDTHB+0.10%EURCAD+0.10%EURNZD+0.10%USDJPY+0.10%CHFSGD-0.09%CADJPY+0.09%USDCNH-0.05%USDCOP-0.04%AUDSGD-0.02%NZDCAD+0.01%NZDUSD+0.01%EURDKK+0.01%USDHKD+0.01%USDCAD0.00%UKOIL-2.43%USOIL-2.09%COCOA-1.36%W1+1.14%C1+0.83%COFFEE+0.82%GAUUSD+0.69%XAUUSD+0.69%COTTON+0.60%GAGUSD+0.57%XAGUSD+0.55%S1+0.52%BTCUSD+0.65%ETHUSD+6.15%USDTUSD-0.04%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.15%ZECUSDT+2.33%DOGEUSD-1.82%XMRUSDT-0.76%LINKUSD+3.21%XLMUSD+0.53%BCHUSDT+0.38%UNIUSD-2.22%LTCUSD-4.60%SUIUSD-0.96%HBARUSDT-0.25%TONUSD+12.52%TAOUSDT-0.59%AAVEUSD-1.26%DOTUSDT+0.28%ICPUSDT-4.15%ONDOUSDT+0.14%WLDUSDT+0.47%ARBUSDT-3.10%JUPUSDT-0.14%ATOMUSDT-0.58%INJUSDT+0.80%STXUSDT+0.08%FETUSDT-1.98%SEIUSDT-0.61%PYTHUSDT+1.02%TIAUSDT-1.42%IMXUSDT-1.75%GRTUSDT-0.64%OPUSDT-2.99%WIFUSDT+0.80%IOTAUSDT+4.29%AXSUSDT-0.24%POLUSDT+1.35%FARTCOINUSDT+2.13%EOSUSDT+3.34%DYDXUSDT-1.68%GALAUSDT-0.12%ORDIUSDT+1.11%NOTUSDT+1.29%RONINUSDT+2.94%
GP

Guardian Pharmacy Services, Inc. (GRDN)

NYSE • Healthcare

$42.1
-$0.28 (-0.7%)
Market closed

Last close at October 5, 2026 at 20:00 UTC

Open$42.6
Day Range$42.08 - $42.74
Avg. Volume (3M)733.7K
Market Cap$2.6B
P/E Ratio40.1
52 Week Range
$23.14$48.33
Next EarningsIn 34 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$351.7M100%
Gross Profitminus cost of goods$80M23%
Operating Incomeminus R&D and overhead$20.6M6%
Net Incomeminus taxes and the rest$21.8M6%

In plain terms: out of every $100 in revenue, Guardian Pharmacy Services, Inc. keeps $6 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.4B
Net Income (TTM)
$65.9M
EPS (TTM)
$1.05
ROA (TTM)
14.86%
Current Ratio
1.65
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+37.0%Q1 2026$0.37
+20.8%Q2 2026$0.29
+10.8%Q3 2026$0.29
Next

Nov 9

in 34 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +10.8%

Guardian Pharmacy Services topped consensus on both revenue and adjusted EPS in the second fiscal quarter of 2026, with preliminary results reported on 2026-08-06: adjusted EPS of $0.29 beat the $0.26 estimate by 10.8%, while revenue of about $351.8 million exceeded the roughly $340.4 million consensus by 3.3%. Revenue rose 2.2% from about $344.3 million a year ago, and at the operating line the business posted about $20.6 million of income as operating margin held around 5.9%. Gross margin near 22.8% framed the quarter’s profit profile. Net income was about $21.9 million, up 142.2% from about $9.0 million a year earlier, while adjusted EPS increased 26.1% from $0.23. The company generated operating cash flow of about $36.1 million and repurchased about $30.3 million of stock, leaving cash generation alongside capital return as part of the quarter’s read-through.

View full earnings history

About Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. provides pharmacy services for residential and long-term care settings in the United States and operates in healthcare services tied to medication management and care support. The company, which trades on the NYSE as GRDN, generated $1.4 billion in revenue in FY2025.

Name
Guardian Pharmacy Services, Inc.
CEO
Fred Burke
Website
guardianpharmacy.com
Industry
Healthcare
Year Founded
2003
Employees
3,600

Today's Snapshot

AI-generated

GRDN closed 0.7% lower at 42.10, against a firmer sector. Shares changed hands at about two-fifths of its usual level.

Trading Volume

Below 10d avg (493.2K)

189K

vs S&P 500 Today

Underperforming Market

-1.42%

Updated: October 5, 2026 at 20:06 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
GRDN presents a constructive bias as the market price sits above several short- and medium-term averages and well clear of the long-term trend level, supporting the buy stance. Momentum is mixed—RSI around neutral and MACD modestly positive—but money flow shows buying interest and the pivot sits near current price, while ADX signals only a weak trend so conviction is moderate. ATR suggests typical volatility and OBV is not confirming the advance, which tempers enthusiasm. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$36.77 - $42.09
    Buy
  • RSI (14)50.90
    Neutral
  • Stochastic %K (14, 3, 3)20.91
    Neutral
  • MACD Level (12, 26)0.13
    Neutral

Peers & Related Assets

TWSTTwist Bioscience Corporation
$205+8.7%
TXG10x Genomics, Inc.
$97.74+4.5%
EWTXEdgewise Therapeutics, Inc.
$40.3-2.7%
NHCNational HealthCare Corporation
$230.37+1.2%
MDPediatrix Medical Group, Inc.
$26.1+0.5%
NUVBNuvation Bio Inc.
$4.95-3.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.